Research Articles | Page 35 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients Jul 2020 Leukemia Myelodysplastic Syndromes (MDS)
Targeting the Microenvironment in MDS: The Final Frontier Jul 2020 Frontiers in Pharmacology Myelodysplastic Syndromes (MDS)
Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International PNH Registry Jul 2020 European Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Kinetics of Pre-Myelodysplastic Syndromes Blood Values Correlate with Disease Risk and Survival Jul 2020 Hematological Oncology Myelodysplastic Syndromes (MDS)
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag Jul 2020 Leukemia Aplastic Anemia
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Jul 2020 Blood Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Genetics of Progression From MDS to Secondary Leukemia Jul 2020 Blood Myelodysplastic Syndromes (MDS)
Where There's Smoke, There's Fire: Inflammation Drives MDS Jul 2020 Trends in immunology Myelodysplastic Syndromes (MDS)
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry Jul 2020 Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study Jul 2020 Leukemia Research Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)